&w=3840&q=100)
Zee Entertainment slides 4% on Q1 report; what should investors do now?
At 11:54 AM, Zee Entertainment share price was trading 2.84 per cent lower at ₹129.95 per share on BSE. In comparison, the BSE Sensex rose 0.28 per cent to 82,419.39.
The market capitalisation of the company stood at ₹12,481.95 crore. The 52-week high of the company stood at ₹154.85 per share, and the 52-week low was at ₹89.29.
Zee Entertainment Q1 results
In the June quarter (Q1FY26), Zee Entertainment reported a consolidated net profit of ₹143.7 crore as compared to ₹118.1 crore, up 22 per cent. Its revenue, on the other hand, declined 14 per cent Y-o-Y to ₹1,824.8 crore as against ₹2,130.5 crore a year ago.
The Earnings before interest, tax, depreciation and amortisation (Ebitda) for the quarter under review stood at ₹228 crore as against ₹271.6 crore. The Ebitda margins remained stable at 12.5 per cent, as compared to 12.7 per cent a year ago.
Brokerages' view on Zee Entertainment
Motilal Oswal has reiterated 'Neutral' on the stock, but has cut the target to ₹130 per share from ₹150. The brokerage believes that even though the valuations remain attractive at 13x FY27E earnings per share (EPS), persistent weakness is seen in ad revenue.
In Q1, advertisement revenue of the company declined 17 per cent Y-o-Y to ₹830 crore, as domestic ad revenue dipped 19 per cent Y-o-Y, impacted by a slowdown in fast-moving consumer goods (FMCG) spending and an extended sports calendar (IPL).
Further, a sustained recovery in domestic advertisement revenue and a favourable outcome in ongoing litigation for ICC rights with Star will remain key for rerating, according to Motilal Oswal.
ICICI Securities has maintained a 'Buy' with a target of ₹185 per share as it expects losses to reduce further with operating leverage.
JM Financial Institutional Securities has also maintained 'Buy' with a revised target of ₹200 per share from ₹190.
"We expect a gradual recovery to both ad-revenues and margins. We build -1 per cent/16 revenue growth/Ebitda margin for FY26E. No equity dilution however, limits impact on earnings. With no promoter stake raise now, value unlocking through music remains a key trigger," the brokerage noted.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Bajaj Housing Finance's net profit up 20.86% in Q1 FY26
NEW DELHI: Bajaj Housing Finance has reported a growth of 20.86 per cent in its net consolidated profit in the first quarter of the financial year 2025-26. The company's profit after tax stood at ₹583.30 crore in Q1 FY26 as against ₹482.61 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹2,618.45 crore in Q1 FY26, a growth of 18.55 per cent from ₹2,208.73 crore it recorded in the similar quarter last year. As of June 30, 2025, the company's net worth stood at ₹20,508.37 crore, debt-equity ratio was 4.31, total debts to total assets was 0.81, gross non-performing assets (NPA) was 0.30%, net NPA was 0.13%, capital to risk-weighted assets ratio was 26.94% and liquidity coverage ratio was 210.57%. The company's assets under management (AUM) grew by 24 per cent to ₹1.20,420 crore as of 30 June 2025 from ₹97,071 crore as of 30 June 2024. Loan losses and provisions for Q1 FY26 was ₹41 crore as against ₹10 crore in Q1 FY25. Provisioning coverage ratio on stage 3 assets at 56%.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Discovery Global Management exits SpiceJet, sells 2.2% stake for ₹119 crore
Global macro hedge fund Discovery Capital Management on Wednesday exited SpiceJet by selling its entire 2.2 per cent stake in the domestic carrier for₹ 119 crore through an open market transaction. The US-based Discovery Capital Management through its affiliate Discovery Global Opportunity (Mauritius) Ltd offloaded 3,11,53,621 shares, representing a 2.20 per cent stake in Gurugam-based SpiceJet, as per the bulk deal data on the BSE. The transaction was executed at an average price of ₹38.14 apiece, taking the total deal value to ₹118.82 crore. Meanwhile, Plutus Wealth Management bought 2.45 crore shares or 1.73 per cent stake in SpiceJet for ₹93.39 crore. The shares were picked up at an average price of ₹38.12 apiece. Following the stake buy, Plutus Wealth Management's holding in SpiceJet rose to 4.44 per cent from 2.71 per cent. Details of other buyers of SpiceJet shares could not be ascertained on the bourse. SpiceJet rose 5.75 per cent to close at ₹40.29 apiece on the BSE. On Wednesday, the Supreme Court dismissed a plea of KAL Airways and Kalanithi Maran seeking damages of over ₹1,300 crore from SpiceJet in a long-standing share transfer dispute. A bench of Justices P S Narasimha and A S Chandurkar upheld the Delhi High Court's order of May 23 dismissing their plea on grounds of delay. KAL Airways and Kalanithi Maran had initially sought damages of over ₹1,300 crore during the arbitration proceedings. Maran and KAL Airways were former promoters of SpiceJet.
The Hindu
3 hours ago
- The Hindu
Natco Pharma to acquire stake in South African firm Adcock Ingram for ₹2,000 crore
Natco Pharma has made an offer to acquire nearly 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). The proposal to acquire the stake from minority shareholders in an all cash deal is a strategic investment aimed at to expanding geographic footprint in South Africa, Natco said on Wednesday. Founded in 1890, AIHL has a diverse product portfolio, from generic and branded formulations, critical-care hospital products to consumer and home-care products. It operates across four segments -prescription, consumer, OTC and hospitals. The acquisition is expected to be completed by 2025. Post-acquisition, AIHL will continue to operate as a private South African business with Bidvest holding 64.25% and Natco 35.75%, including a prior held 0.80% stake, in the company. Post-transaction, Natco will consolidate 35.75% of AIHL net profits in its financial results. AIHL clocked revenue of $536 million in the financial year June 2024 and profit after tax of $45 million. 'Adcock Ingram is a respectable pharmaceutical company with well-recognised brands and products and maintains a leading position in the South African pharmaceutical market. The proposed transaction will provide Natco Pharma with a well-established entry into the Southern African market. It will also allow us to tap into new revenue streams and expand our footprint in one of the largest and growing emerging markets, while providing a gateway to the African continent,' CEO and Vice-Chairman Rajeev Nannapaneni said. Besides the acquisition, Natco Pharma Board also approved a proposal to incorporate a wholly owned subsidiary in South Africa with an investment of up to Rs.2,100 crore by this year to enter new geographies for growth and increased profitability. It also approved a proposal to liquidate wholly owned subsidiary Time Cap Overseas (TCOL), and directly hold the investment in step down subsidiary NatcoFarma do Brasil. Natco shares closed 2.01% higher at ₹1,034.75 apiece on the BSE.
